PMID- 34861061 OWN - NLM STAT- MEDLINE DCOM- 20220318 LR - 20220318 IS - 1098-2825 (Electronic) IS - 0887-8013 (Print) IS - 0887-8013 (Linking) VI - 36 IP - 1 DP - 2022 Jan TI - Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity. PG - e24163 LID - 10.1002/jcla.24163 [doi] LID - e24163 AB - INTRODUCTION: Chronic hyperglycemia activates the inflammatory pathways and oxidative stress mechanisms with consequent damage to nerve tissue and retina. The Keap1-Nrf2 pathway acts as one of the most important antioxidant pathways of the organism. Variants of Keap1 could affect susceptibility to diabetes and its complications. METHODS: In a case-control study, 400 individuals included type 2 diabetes mellitus (T2DM) patients without complication, with neuropathy, with retinopathy, and healthy individuals were investigated. The levels of glutathione (GSH), glutathione peroxidase (GPx), malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured using chemical methods. Using the PCR-RFLP method, the Keap1 (rs11085735) variants were identified. RESULTS: Neuropathic patients had significantly lower levels of GSH, GPx, and TAC and higher levels of total oxidative status (TOS), MDA, and oxidative stress index (OSI) compared to T2DM patients without complication and controls. Lower levels of GSH and GPx and a higher level of MDA were observed in patients with retinopathy compared with controls. Obesity was associated with significantly lower GPx activity and higher TOS. A significantly higher Keap1 AA genotype was found in patients with neuropathy than T2DM without complication and controls. The presence of Keap1 AA genotype correlated with lower GPx activity compared to CC genotype. CONCLUSIONS: Our study suggests the role of reduced antioxidant system and Keap1 variants in the pathogenesis of T2DM and its complications of neuropathy and retinopathy and also obesity in enhanced oxidative stress. Monitoring oxidative stress parameters in diabetic patients, especially those with complication and their treatment with antioxidants is suggested. CI - (c) 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. FAU - Khalili, Farnaz AU - Khalili F AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Vaisi-Raygani, Asad AU - Vaisi-Raygani A AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Shakiba, Ebrahim AU - Shakiba E AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Kohsari, Maryam AU - Kohsari M AUID- ORCID: 0000-0002-1817-9147 AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Dehbani, Maryam AU - Dehbani M AD - Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Naseri, Rozita AU - Naseri R AD - Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Asadi, Soheila AU - Asadi S AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Rahimi, Ziba AU - Rahimi Z AD - Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Rahimi, Mehrali AU - Rahimi M AD - Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. FAU - Rahimi, Zohreh AU - Rahimi Z AUID- ORCID: 0000-0001-7589-3307 AD - Department of Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran. AD - Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. LA - eng GR - 97937/Kermanshah University of Medical Sciences/ PT - Journal Article DEP - 20211203 PL - United States TA - J Clin Lab Anal JT - Journal of clinical laboratory analysis JID - 8801384 RN - 0 (KEAP1 protein, human) RN - 0 (Kelch-Like ECH-Associated Protein 1) SB - IM MH - *Diabetes Mellitus, Type 2/complications/epidemiology/genetics MH - *Diabetic Neuropathies/epidemiology/genetics MH - *Diabetic Retinopathy/epidemiology/genetics MH - Female MH - Humans MH - Kelch-Like ECH-Associated Protein 1/*genetics MH - Male MH - Middle Aged MH - Obesity/complications/epidemiology/genetics MH - *Oxidative Stress PMC - PMC8761405 OTO - NOTNLM OT - diabetic neuropathy OT - diabetic retinopathy OT - keap1 variants OT - oxidative stress OT - type 2 diabetes COIS- None. EDAT- 2021/12/04 06:00 MHDA- 2022/03/19 06:00 PMCR- 2021/12/03 CRDT- 2021/12/03 17:34 PHST- 2021/11/15 00:00 [revised] PHST- 2021/09/04 00:00 [received] PHST- 2021/11/23 00:00 [accepted] PHST- 2021/12/04 06:00 [pubmed] PHST- 2022/03/19 06:00 [medline] PHST- 2021/12/03 17:34 [entrez] PHST- 2021/12/03 00:00 [pmc-release] AID - JCLA24163 [pii] AID - 10.1002/jcla.24163 [doi] PST - ppublish SO - J Clin Lab Anal. 2022 Jan;36(1):e24163. doi: 10.1002/jcla.24163. Epub 2021 Dec 3.